
Listeria outbreak linked to recalled frozen shakes now blamed for 12 deaths
The infections, which ranged across 21 states, have been traced to recalled products manufactured by Prairie Farms Dairy at a facility in Fort Wayne, Indiana. Swabs collected from the plant's processing area tested positive for listeria, with the investigation ongoing, the Food and Drug Administration stated in a new alert.
The following states have reported cases of listeria tied to the recalled shakes: Alabama, California, Colorado, Connecticut, Florida, Illinois, Indiana, Maryland, Michigan, Minnesota, Missouri, North Carolina, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Washington and West Virginia.
The ongoing outbreak includes illnesses dating back to 2018, with total 20 cases occurring this year and in 2024, according to the U.S. Centers for Disease Control and Prevention.
Of the 38 people for whom information is available, 37 have been hospitalized and 12 deaths have been reported as of Monday. The vast majority of those who were infected with listeria reported living in a long-term care facility or being hospitalized before becoming sick, the CDC said.
The death toll linked to the Prairie Farms Dairy shakes is greater than one in 2024 connected to deli meats made by Boar's Head that resulted in 10 deaths and 57 illnesses in what was labeled the worst listeria outbreak since one in 2011 linked to cantaloupe.
Listeria monocytogenes can cause serious, and sometimes fatal, infections in the young, frail or elderly, as well as in people with weakened immune systems. While healthy individuals may suffer from more minor symptoms, including fever, headache, stiffness, nausea, abdominal pain and diarrhea, the infection can cause miscarriages and stillbirths among pregnant women.
Fresno, California-based food maker Lyons Magnus on Feb. 22 recalled four-ounce Lyons ReadyCare and Sysco Imperial Frozen Supplemental Shakes supplied by Prairie Farms and distributed mostly to nursing homes nationwide.
The recalled products had best-by-dates of February 21, 2025, to February 21, 2026, and came in vanilla, chocolate, strawberry or strawberry banana.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNET
an hour ago
- CNET
The First At-Home Cervical Cancer Screening Wand: Cost, Insurance Coverage and How It Works
Many people dread going into the doctor's office for a Pap smear or HPV test, but that's no longer the only cervical cancer screening option. Now, we have the Teal Wand, the first and only at-home vaginal sample self-collection device for cervical cancer screening in the US. It allows people with a cervix to easily screen themselves for the highly preventable cancer from the comfort of their home. After receiving FDA approval in May, the Teal Wand is now available in California. By 2027, it should be accessible across the US. If you're curious about giving it a try, here's everything you need to know. How the Teal Wand works "The Teal Wand is a self-collection device in which the collected sample is mailed to a lab to test for high-risk HPV using an FDA-approved Primary HPV test," said Kara Egan, Teal Health's CEO and co-founder. The Teal Wand requires a prescription, which you can get through Teal Health on First, you fill out a medical eligibility questionnaire, order a screening kit and schedule a 10-minute virtual visit with a Teal provider. (You can see the OBGYNs and nurse practitioners on Teal's team here.) During the appointment, the provider will review your screening history and discuss the process. After the prescription is approved, a kit will be shipped directly to your home. Collecting your sample at home only takes a few minutes. Print and video instructions can help guide you, and Teal support can answer questions. When you're done, simply package your sample and ship it to a CLIA-certified lab with the materials provided. (CLIA, or Clinical Laboratory Improvement Amendments, are regulations requiring any facility examining human specimens, like tissue, blood and urine, for diagnosis, prevention or treatment purposes, to be certified by the Secretary of the Department of Health and Human Services.) After the lab processes your sample, a Teal provider reviews the results in accordance with the screening guidelines defined by the American Society for Colposcopy and Cervical Pathology (ASCCP). You'll receive results in your secure Teal portal within about a week after sending your sample. You'll be given the opportunity to virtually connect with a Teal provider to discuss any next steps. If follow-up care is needed, the Teal team will coordinate your referral. What the Teal Wand tests for Just like in the clinician's office, your sample is tested for 14 types of high-risk HPV (Human Papillomavirus) that present the highest risk of causing cervical cancer, Egan said. According to the World Health Organization, 99% of cervical cancer cases are linked to HPV infections. Primary HPV tests are the most sensitive tests recommended by the American Cancer Society and the US Preventive Services Task Force for cervical cancer screening. According to Teal Health, the Teal Wand uses the Roche cobas Primary HPV test, which is the same test your doctor would use. Teal's national clinical trial also concluded that "self-collection using the Teal Wand is as accurate as going into the clinic where a provider collects the sample using a speculum and tests for HPV." The Teal Wand is simply a different way of collecting the sample. Teal Health Who can use the Teal Wand? There are three types of cervical cancer tests: Primary HPV testing every five years, Pap tests every three years and co-tests that combine both an HPV test with a Pap test every five years. According to the ASCCP's guidelines, Primary HPV testing through self-collection, which the Teal Wand uses, is suitable for people at average risk for cervical cancer. Teal Health follows the American Cancer Society's guidelines, which recommend HPV testing every five years for people aged 25 to 65 who have an intact cervix. Note that the US Centers for Disease Control and Prevention (CDC) recommends that people between the ages of 30 and 65 get either an HPV test, a Pap test or both as a co-test. (This is different from the American Cancer Society's recommendation, which starts at age 25 instead of 30.) If you're considered at risk of cervical cancer, the CDC recommends that you start getting Pap tests as early as age 21. For those over age 65, consult your doctor. You may not need to be screened anymore if you've received normal or negative results from at least three Pap tests or two HPV tests in the past 10 years, or if you've had your cervix removed during a total hysterectomy for noncancerous conditions like fibroids. Regardless of how, it's important to get screened regularly, even if you've been vaccinated against HPV. If you're not sure which test is right for you, your doctor can help you decide. Who shouldn't use the Teal Wand? Egan said that self-collection with the Teal Wand is not currently recommended for: patients with a history of cancer in the reproductive system patients with HIV (human immunodeficiency virus) patients with DES (diethylstilbestrol, a synthetic form of estrogen) exposure patients with immunosuppression patients who have had a treatment for cervical precancer, such as LEEP (Loop Electrosurgical Excision Procedure) or cold knife cone patients who are pregnant or within six weeks of giving birth Does the Teal Wand replace a Pap smear? The Teal Wand is not the same as a Pap smear (cervical cytology). Instead of in-office, clinician-collected samples with a speculum, like you'd have with a Pap smear, Primary HPV screening allows for self-collected samples. Teal describes a Pap smear as being less sensitive compared to HPV testing because it can only detect cell changes once they've happened, a potential sign that cancer is already present. That's why Pap smears are performed more often than Primary HPV testing (every three years versus five years). On its own, a Pap also doesn't test for HPV, which is the primary cause of almost all cervical cancers. "Universally, a cervical cancer screening is often called a Pap smear, but Pap smear, along with the HPV test, are both types of tests for cervical cancer screening," Egan said. "Screening for HPV using the Teal Wand is an alternative to screening in person." In other words, once you screen using the Teal Wand, you don't need to do the test again in your doctor's office. However, if your results are abnormal and positive for HPV, you may need to get additional in-person testing, such as a colposcopy or a Pap smear, to check for cell changes. Your Teal provider will advise you accordingly, per medical guidelines, based on the HPV type detected and your screening history. While Teal Health aims to help people stay up-to-date on cervical cancer screening, it's always recommended to continue yearly in-person preventive care visits. Teal Health Teal Wand costs and health insurance With select insurance companies, the full at-home screening experience with telehealth consults is available for $99. Without insurance, it's $249, but is eligible for HSA/FSA reimbursement. Teal Health is currently working with the following insurance plans in California: Cigna, Aetna, Anthem Blue Cross, Blue Shield of California and United Healthcare. The company aims to expand its coverage and also provide financial assistance when needed. When will the Teal Wand be available outside California? Teal Health is planning to have the Teal Wand available across the US before the end of 2026. What's the goal with the Teal Wand? According to Egan, Teal Health is on a mission to improve women's healthcare experiences. Teal Health is also a member of the Cervical Cancer Roundtable, a collaboration between the American Cancer Society and the Biden Cancer Moonshot, a coalition of industry leaders working to eliminate cervical cancer as a public health concern in the US. "By creating the option for a woman to screen for cervical cancer from the comfort of home and providing telehealth follow-up, Teal can increase access to this life-saving cancer screening, get more women screened and work toward eliminating cervical cancer in the US, as it is the only cancer nearly 100% preventable with proper screening," said Egan.


Business Insider
2 hours ago
- Business Insider
Why Is Catheter Precision Stock (VTAK) Up 70% Today?
Catheter Precision (VTAK) stock saw major gains on Monday after the medical device company's LockeT was registered and approved in the UK. This was the final step needed to begin sales of the suture retention device in the UK after it received a CE Mark for European approval and distribution in May 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Catheter Precision will sell LockeT through UK-based value-added distributor HC21. The company has already worked with this distributor for years, selling other products in the region. This agreement was updated to include sales of LockeT. Fatih Ayoglu, Catheter Precision Sales Manager EMEA & APAC, said, 'We are proud to announce the approval of LockeT for use in the United Kingdom, marking a significant milestone in our mission to support healthcare systems with innovative, patient-centric solutions. With the NHS recently achieving its first reduction in waiting lists in 17 years, LockeT is poised to contribute meaningfully to this momentum by helping clinicians deliver more treatments, more efficiently.' Catheter Precision Stock Movement Today Catheter Precision stock was up 72.03% in pre-market trading on Monday, following a 10.74% fall on Friday. The company's shares have also declined 69.54% year-to-date and 93.78% over the past 12 months. Today's movement came with heavy trading, as some 23 million shares changed hands, compared to a three-month daily average of about 92,000 units. Is Catheter Precision Stock a Buy, Sell, or Hold? Turning to Wall Street, coverage of Catheter Precision stock is thin. Fortunately, TipRanks' AI analyst Spark has it covered. Spark rates VTAK stock a Neutral (41) with no price target. It cites 'significant financial and operational challenges with ongoing losses and negative cash flow' as reasons for this stance.


CBS News
3 hours ago
- CBS News
California is seeing spike in tick-borne illness anaplasmosis, experts warn
Ticks carrying a disease called anaplasmosis are spreading quickly throughout California, experts say. The disease is mainly showing up in dogs. Since dogs spend more time outdoors, experts say rising cases in pets could signal that humans may soon be at greater risk. More than half of the state's counties are now considered "high risk," according to the nonprofit group Companion Animal Parasite Council's data. "There's not a lot of awareness in California because most people think it's primarily a disease of the Upper Midwest and Northeast," said Dr. Jane Sykes, a professor of veterinary medicine at UC Davis. The culprit is the same western black-legged tick that spreads Lyme disease. In dogs, anaplasmosis can cause fever, fatigue, loss of appetite, and weight loss. In some cases, dogs may also experience nosebleeds, neck pain, or even seizures. "They kind of look depressed, dull, they don't want to move," Sykes said. "They have a fever, and sometimes they can develop vomiting." Veterinarians say diagnosis can be difficult, especially if owners don't mention that their dogs are often in tick-prone areas, making awareness critical. The good news: the illness can be treated quickly with antibiotics. "It doesn't matter when you give the antibiotics, it just costs more to have your dog in the hospital, not feeling well, going back in and out of veterinary clinics before the right diagnosis is made," Sykes explained. According to the Companion Animal Parasite Council, between 2021 and 2024 the number of dogs testing positive for the illness nearly tripled. More than half of California's counties are now at "high risk," including Yolo, Placer, and El Dorado counties. Veterinarians say the best way to keep dogs safe is year-round tick and flea prevention, as well as examining pets after walks in grassy or wooded areas.